FDA Inspection 1172108 — LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. — FEI 1220948

The FDA completed an inspection of LeMaitre Vascular, Inc. on June 15, 2022 in Burlington, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 15, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Compliance: Devices
Location
Burlington, MA (United States)

Citations

IDCFRDescription
310821 CFR 820.70(e)Contamination control, Lack of or inadequate procedures
312821 CFR 820.90(a)Nonconforming product control
323221 CFR 820.72(a)Equipment suitability & capability
369621 CFR 820.100(b)Documentation
54621 CFR 820.75(a)Lack of or inadequate process validation